Integrated analysis of systemic inflammation and tumor immune features identifies biologically distinct patient subgroups with differential survival outcomes, outperforming conventional biomarkers ...
Genomic Profiling Identifies Outcome-Relevant Mechanisms of Innate and Acquired Resistance to Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy in Lung Cancer The ...
Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology The ideas and opinions ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating the ...
(L) Giles Robinson, MD, St. Jude Division of Neuro-oncology director, Department of Oncology, co-corresponding author on the Neuro-Oncology and Cancer Research studies and (R) Xin Zhou, PhD, St. Jude ...
Stratified random sampling is a method of sampling that divides a population into smaller groups that form the basis of test ...
Castle Biosciences will present TissueCypher Barrett’s Esophagus test data at DDW 2025, emphasizing risk stratification and personalized patient management. Castle Biosciences, Inc. will present new ...
Chinese Medical Journals Publishing House Co., Ltd. Electronic health record (EHR) data from 51,400 participants, including demographic characteristics, clinical information, anthropometric measures, ...
This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies. Objectives: Risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results